Delivery Order SPE2DB22D1202-SPE2DB25FVHF8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count package) with a ceiling value of $1,278.01. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1.5 mg-30 mcg Junel FE tablets (28-count) on August 7, 2025, with a ceiling value of $1,178.79. This non-set-aside, firm fixed-price delivery order is set to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement under the company's existing contract vehicles with the DLA....
- The Defense Logistics Agency awarded a delivery order valued at $3,427.92 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count package) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.20 to AmerisourceBergen Drug Corp for the supply of Junel 1.5 mg-30 mcg tablets (21-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,383.88 firm fixed price delivery order is for the supply of the drug Junel FE 1 mg-20 mcg tablet, a contraceptive medication, to support military healthcare programs. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This delivery order, valued at $4,852.87, was awarded on July 28, 2025, to AmerisourceBergen Drug Corp for the supply of JUNEL FE 1MG-20 168S pharmaceutical product. The contract is funded through the Defense Medical Supply Chain, a defense-focused federal agency responsible for managing medical procurement for military and veteran healthcare systems. The ultimate completion date is set for August 22, 2025, and the contract employs firm fixed pricing with no set-aside designation, indicating...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 13, 2025, procures Junel FE 1 mg-20 mcg tablets (28-count packages) valued at $2,785.79 with a completion date of August 14, 2025. The award represents a competitive, non-set-aside contract issued under firm fixed pricing terms. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The Defense Logistics Agency, under the Department of Defense, serves as the funding federal...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Junel FE 1 mg-20 mcg tablets in packages of 28. The $1,328.80 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.18 firm fixed-price contract is for the delivery of Junel FE 1 mg-20 mcg tablets, a contraceptive medication, to support military healthcare programs. The contract has a period of performance through February 3, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHF8Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on August 13, 2025, by the Defense Logistics Agency for the supply of Junel Fe 1 mg-20 mcg tablets in a 28-count package. This firm fixed-price delivery order, valued at $6,653.00, is scheduled for completion by August 14, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation and is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order represents a continuation of AmerisourceBergen Drug Corp's role as a critical pharmaceutical supplier to the Defense Health Agency and broader military healthcare systems. As the prime vendor under the DLA's pharmaceutical support vehicle, the contractor maintains an extensive portfolio supporting military medical needs across multiple therapeutic domains. The pharmaceutical delivery covered under this order supports the Defense Logistics Agency's mission to supply essential medications to military and veteran healthcare systems, enabling continued access to reproductive health pharmaceuticals for eligible beneficiaries across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/13/25 |